HOME >> BIOLOGY >> NEWS
Molecule that destroys bone also protects it, new research shows

BUFFALO, N.Y. -- An immune system component that is a primary cause of bone destruction and inflammation in autoimmune diseases such as rheumatoid arthritis actually protects bone in the oral cavity from infectious pathogens that play a major role in periodontal disease in humans, research at the University at Buffalo has shown.

The component, IL-17, was recognized only in the past 18 months to be a primary cause of bone destruction and inflammation in autoimmune diseases. Therapies that target IL-17 or its cellular receptor currently are being developed.

However, a UB molecular biologist has discovered that, in contrast to its action in rheumatoid arthritis(RA), IL-17 actually protects bone in the oral cavity from infectious pathogens such as Porphyromonas gingivalis, a bacterium that plays a major role in most periodontal disease in humans.

The research findings appear in the current (May) issue of the journal Blood.

Sarah L. Gaffen, Ph.D., associate professor of oral biology in the UB School of Dental Medicine and associate professor of microbiology and immunology in the UB School of Medicine and Biomedical Sciences, is senior author. Jeffrey J. Yu, a medical student and doctoral candidate who is a researcher working in Gaffens lab, is first author.

Gaffen and colleagues conducted the research in mice bred to have no receptors for IL-17. Other researchers had shown previously, using rats and mice as animal models, that blocking the receptor for IL-17 could be an effective therapy for RA and possibly for other autoimmune diseases such as multiple sclerosis, colitis, psoriasis and lupus.

The effects of an IL-17 deficiency in periodontal disease, however, were unknown, so Gaffens lab set out to investigate.

"I predicted these mice without the IL-17 receptor were going to be protected from periodontal bone loss, just like theyre protected from arthritic bone loss," Gaffen said. "In fact, we got the opposite
'"/>

Contact: Lois Baker
ljbaker@buffalo.edu
716-645-5000 x1417
University at Buffalo
8-May-2007


Page: 1 2 3

Related biology news :

1. Molecule blocks gene, sheds light on liver cancer
2. Howard C. Berg honored with Outstanding Investigator in Single Molecule Biology Award
3. Molecule discovered to be key to pain sensitivity
4. Molecules in blood foretell development of preeclampsia
5. Molecule by molecule, new assay shows real-time gene activity
6. Molecule does more than slice and dice RNA
7. Molecule links Down syndrome to Alzheimers
8. Molecule crucial for processing non-coding RNA identified
9. Molecule on immune cells linked to sexual transmission of HIV
10. Molecule that usually protects infection-fighting cells may cause plaque deposits inside arteries
11. Molecule that helps DNA replicate may make good target for cancer therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/18/2019)... ... March 18, 2019 , ... uBiome, ... industry and the third highest quality portfolio following Seres Health and Nestle, as ... Christian Moser, and Theodor Myfleler. uBiome executives Dr. Jessica Richman, PhD, co-founder and ...
(Date:3/14/2019)... , ... March 13, 2019 , ... Bode Technology (Bode), a leading provider ... on more than 100,000 sexual assault kits. As thousands of untested kits are identified ... sexual assault kit backlogs . Bode has tested more than 50,000 kits in the ...
(Date:3/12/2019)... SANTA CLARA, Calif. (PRWEB) , ... March 12, ... ... world leader in strong multi-factor authentication and combined technology all-in-one smart cards, announced ... combined with FIDO strong authentication: the Fingerprint Biometric and Dynamic CVV Payment cards. ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... WHITEHOUSE, N.J. (PRWEB) , ... March 19, 2019 , ... ... and is a great opportunity to see the most cutting-edge cancer research. The Visikol ... work with 3D cell culture assays as well as their digital ...
(Date:3/19/2019)... ... ... will review strategies for data management in modular and adaptive clinical trials. , Participants will:, ... 30 percent, reducing cost while increasing quality, achieving clinical site set-up faster , ... reducing risk and impact on trial success, trial teams, and trial execution , ...
(Date:3/15/2019)... (PRWEB) , ... March 15, ... ... of 100% equity in American Process Inc. and affiliate companies including AVAPCO ... Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D center in Thomaston, ...
(Date:3/14/2019)... DESERT, Calif. (PRWEB) , ... March 14, 2019 ... ... issued a press release announcing that its Canadian partner, the Eye Machine Canada ... Canada, using Nova Oculus’s pioneering technology for treating Age-Related Macular Degeneration (AMD). , ...
Breaking Biology Technology:
Cached News: